Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07362433Phase 4Not Yet Recruiting

Trial of an AI-enabled Digital Stethoscope to Improve Antibiotic Stewardship

Role: collaborator

NCT07155902Not ApplicableNot Yet Recruiting

Implementing WHO HEARTS-D Guidelines in Bangladesh for Diabetes Control and Prevention

Role: collaborator

NCT03959956Completed

Improving Paediatric Pneumonia Diagnosis Using Digital Auscultation

Role: collaborator

NCT03876249Unknown

The Long-term Effect of RSV Infection

Role: collaborator

All 4 trials loaded